Long-term Outcome and Pattern of Relapse after Neoadjuvant Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 2-positive Primary Breast Cancer

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Term Outcome ◽

Long Term Outcome ◽

Original Articles: Bladder Cancer: Long-Term Outcome Related to Epidermal Growth Factor Receptor Status in Bladder Cancer

The Journal of Urology ◽

10.1016/s0022-5347(01)67604-3 ◽

1995 ◽

Vol 153 (3S) ◽

pp. 919-925 ◽

Cited By ~ 96

Author(s):

Kilian Mellon ◽

Chris Wright ◽

Peter Kelly ◽

C.H. Wilson Horne ◽

David E. Neal

Keyword(s):

Bladder Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Term Outcome ◽

Long Term Outcome ◽

Receptor Status ◽

Neoadjuvant chemotherapy with biosimilar trastuzumab in human epidermal growth factor receptor 2 overexpressed non-metastatic breast cancer: patterns of use and clinical outcomes in India

ecancermedicalscience ◽

10.3332/ecancer.2021.1207 ◽

2021 ◽

Vol 15 ◽

Author(s):

Anjana Joel ◽

Josh Thomas Georgy ◽

Divya Bala Thumaty ◽

Ajoy Oommen John ◽

Raju Titus Chacko ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Patterns Of Use ◽

Evaluation of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Status Before and After Neoadjuvant Chemotherapy in Breast Cancer Patients

Indian Journal of Surgery ◽

10.1007/s12262-020-02380-y ◽

2020 ◽

Author(s):

Adarsh Verma ◽

Amrita Ghosh Kar ◽

Ram Niwas Meena ◽

S. C. U. Patne ◽

Shashi Prakash Mishra ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Before And After ◽

Enhanced Epidermal Growth Factor Receptor Signaling in MCF7 Breast Cancer Cells after Long-Term Culture in the Presence of the Pure Antiestrogen ICI 182,780 (Faslodex)*

Endocrinology ◽

10.1210/endo.142.7.8259 ◽

2001 ◽

Vol 142 (7) ◽

pp. 2776-2788 ◽

Cited By ~ 108

Author(s):

Richard A. McClelland ◽

Denise Barrow ◽

Tracie-Ann Madden ◽

Carol M. Dutkowski ◽

Joanna Pamment ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Breast Cancer Cells ◽

Growth Factor Receptor ◽

Pure Antiestrogen ◽

Epidermal Growth ◽

Growth Factor Receptor Signaling

Prognostic value of neutrophil-to-lymphocyte ratio in human epidermal growth factor receptor 2-negative breast cancer patients who received neoadjuvant chemotherapy

Scientific Reports ◽

10.1038/s41598-020-69965-1 ◽

2020 ◽

Vol 10 (1) ◽

Author(s):

Soong June Bae ◽

Yoon Jin Cha ◽

Changik Yoon ◽

Dooreh Kim ◽

Janghee Lee ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Prognostic Value ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Impact of the Relative Dose Intensity of Neoadjuvant Chemotherapy With Anthracycline Followed by Taxane on the Survival of Patients With Human Epidermal Growth Factor Receptor 2-negative Breast Cancer: The JONIE1 Study

Anticancer Research ◽

10.21873/anticanres.14863 ◽

2021 ◽

Vol 41 (2) ◽

pp. 1063-1068

Author(s):

AKIMITSU YAMADA ◽

KYOKO NAKAZAWA ◽

KOHEI AKAZAWA ◽

KAZUTAKA NARUI ◽

ITARU ENDO ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Dose Intensity ◽

Relative Dose Intensity ◽

A Human Epidermal Growth Factor Receptor 2 Expression-based Approach to Neoadjuvant Chemotherapy for Operable Breast Cancer

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyq020 ◽

2010 ◽

Vol 40 (7) ◽

pp. 620-626 ◽

Cited By ~ 1

Author(s):

T. Ishikawa ◽

D. Shimizu ◽

T. Sasaki ◽

S. Morita ◽

M. Tanabe ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Operable Breast Cancer ◽

UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2–positive subgroup

European Journal of Cancer ◽

10.1016/j.ejca.2019.09.014 ◽

2019 ◽

Vol 122 ◽

pp. 91-100

Author(s):

Véronique D'Hondt ◽

Jean-Luc Canon ◽

Lise Roca ◽

Christelle Levy ◽

Jean-Yves Pierga ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Long Term Results ◽

Epidermal Growth ◽

Positive Breast Cancer

Pathological responses and survival of patients with human epidermal growth factor receptor 2-positive breast cancer who received neoadjuvant chemotherapy including trastuzumab

Breast Cancer ◽

10.1007/s12282-012-0424-4 ◽

2012 ◽

Vol 21 (5) ◽

pp. 563-570 ◽

Cited By ~ 4

Author(s):

Hideyuki Ohzawa ◽

Takashi Sakatani ◽

Toshiro Niki ◽

Yoshikazu Yasuda ◽

Yasuo Hozumi

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Positive Breast Cancer

Efficacy and safety of neoadjuvant chemotherapy with concurrent liposomal-encapsulated doxorubicin, paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive breast cancer in clinical practice

International Journal of Clinical Oncology ◽

10.1007/s10147-014-0727-x ◽

2014 ◽

Vol 20 (3) ◽

pp. 480-489 ◽

Cited By ~ 4

Author(s):

Joaquín Gavilá ◽

Ángel Guerrero ◽

Miguel Ángel Climent ◽

Aranzazu Fernández ◽

Francisco Gozalbo ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Efficacy And Safety ◽

Epidermal Growth ◽

Positive Breast Cancer